跳至主要内容
临床试验/CTRI/2022/02/040365
CTRI/2022/02/040365尚未招募2 期

A prospective single center randomized double arm, open labeled comparative clinical trial to evaluate the effectiveness of Siddha medicine MV Kashayam VS standard conventional treatment among RT-PCR positive COVID 19 patients

Harshana Herbal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Patient positive with Rt PCR test
  • 2 The age group of 15 to 60 years
  • 3 Patients with mild and moderate symptoms of COVID 19
  • 4 Patients of both sexes and willing to accept the treatment method

排除标准

  • 1 RT PCR negative patients
  • 2 Patients less than 15 years of age and above 60 years of age
  • 3 Pregnant and breastfeeding women
  • 4 Patients with severe COVID 19 symptoms
  • 5 Patients with other systemic malignant diseases such as malignant tumors, mental
  • illness etc., which the researchers consider unsuitable for participation in the study
  • 6 Allopathic antiviral treatment patients.
  • 7 Not willing to continue the treatment
  • 8. Patient discharge against medical advice
  • 9 Patients participating in other clinical trails

研究者

发起方
Harshana Herbal

相似试验